Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects
Clinical trial NCT02144714 · COMPLETED
Trial details
- NCT number
- NCT02144714
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-09-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.